NIBSC 国际标准物质

94/762

Influenza Virus infectious RESVIR-8 (H3N2)

94/766

Influenza Virus infectious NIB-34 (H3N2)

94/784

Interferon alpha (Human, leukocyte derived)WHO International Standard

94/786

Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard

94/790

MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard

95/510

Influenza Antigen A/Texas/36/91

95/516

Influenza Antigen A/Johannesburg/33/94

95/522

Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard

95/524

Influenza anti A/Johannesburg/33/94 Serum(sheep)

95/528

Folate, Whole Blood Haemolysate WHO International Standard

95/542

MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard

95/544

Interleukin-12 (Human, rDNA derived) WHO Reference Reagent

95/554

Interleukin-15 (Human, rDNA derived) WHO Reference Reagent

95/564

Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)

95/566

Interferon alpha-2b (Human, rDNA derived) WHO International Standard

95/568

Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard

95/572

Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard

95/574

Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard

95/580

Interferon alpha-2c (Human, rDNA derived) WHO International Standard

95/584

Anti-hepatitis E Serum, Human WHO Reference Reagent

95/646

Parathyroid Hormone 1-84, human, recombinant (1st International Standard)

95/650

Interferon alpha-2a (Human, rDNA derived) WHO International Standard

95/668

Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)

95/674

Anti-Meningococcal Serogroup A mAb

95/678

Anti-Meningococcal Serogroup C mAb

96/528

Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)

96/532

FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent

96/534

Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent

96/538

Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent

96/556

Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard

96/564

Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent

96/572

MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent

96/578

MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent

96/602

Luteinizing Hormone, Human, recombinant WHO International Standard

96/666

Anti-Human Globulin International Reference Reagent

96/668

Prostate Specific Antigen (free) WHO International Standard

96/784

Inhibin B, Human WHO Reference Reagent

96/830

Influenza Virus infectious A/Bayern/7/95

96/836

Influenza Virus infectious RESVIR-9 (H3N2)

96/848

Influenza Virus infectious A/Shenzhen/227/95 (H1N1)

96/850

Influenza Virus infectious NIB-39 (H1N1)

97/518

Influenza Antigen A/Johannesburg/82/96

97/538

Anti-Granulocyte Macrophage Colony Stimulating Factor Serum

97/550

Islet Cell Antibodies WHO Reference Reagent

97/558

Bordetella pertussis anti 69kD serum (sheep)

97/562

Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)

97/564

Bordetella pertussis anti FHA serum (sheep)

97/572

Bordetella pertussis PT anti serum (sheep)

97/574

Bordetella pertussis anti Fim3 serum (sheep)

97/584

Influenza Antigen A/Equine/Newmarket/2/93

97/594

Leptin, Human, Recombinant WHO International Standard

97/596

Influenza Antigen A/Equine/Newmarket/1/93

97/600

Interleukin-2 Soluble Receptor (human, rDNA derived)

97/610

Influenza anti A/equine/Newmarket/1/93 Serum(sheep)

97/612

Influenza anti- A/Nanchang/933/95 (H3N2) HA serum

97/614

Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)

97/626

Leptin, Mouse, Recombinant WHO International Standard

97/642

Bordetella pertussis anti serum (mouse) 1RR

97/646

Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard

97/648

Anti-Measles serum (3rd International Standard)

97/692

Influenza Virus infectious IVR-108 (H3N2)

97/714

Prolactin, Human, recombinant. WHO Reference Reagent

97/722

Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)

97/726

Influenza Virus infectious B/Harbin/7/94

97/748

Influenza Antigen B/Harbin/7/94

97/756

MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent

97/758

MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard

97/760

Influenza Antigen A/Beijing/262/95

98/524

MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard

98/544

Influenza Virus infectious RESVIR-13 (H3N2)

98/572

Diphtheria and Tetanus Antitoxin, Guinea Pig Serum

98/574

Somatropin WHO International Standard

98/580

Prolactin Human, recombinant, glycosylated WHO Reference Reagent

98/582

Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent

98/586

Calcitonin, Salmon. WHO International Standard

98/596

MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent

98/600

Influenza Virus infectious NIB-40 (H5N3)

98/604

Influenza anti B/Harbin/7/94/HA Serum (sheep)

98/610

Influenza Virus infectious ARIV-1 (H5N3)

98/666

Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)

98/686

Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)

98/708

Haemiglobincyanide WHO International Standard

98/714

Tissue Plasminogen Activator, Human, Recombinant WHO International Standard

98/718

Neurotrophin 3

98/722

Meningococcal group A polysaccharide

98/762

Influenza Virus infectious Resvir-14 (H3N2)

98/772

Influenza anti A/Beijing/262/95 Serum (sheep)

98/774

Influenza Antigen B/Shangdong/7/97

98/778

Influenza Virus infectious A/Sichuan/346/98 (H3N2)

99/506

Anti-PT S1 subunit Monoclonal Antibody (1B7)

99/508

Anti-PT S1 subunit Monoclonal Antibody (1D7)

99/510

Anti-PT S1 subunit Monoclonal Antibody (3F11)

99/512

Anti-PT S1 subunit Monoclonal Antibody (10D6)

99/514

Anti-PT S1 subunit Monoclonal Antibody (8G4)

99/516

Anti-PT S1 subunit Monoclonal Antibody (E1E)

99/518

Anti-PT S1 subunit Monoclonal Antibody (E2E)

99/520

Anti-PT S1 subunit Monoclonal Antibody (3F10)

99/522

Anti-PT S1 subunit Monoclonal Antibody (11D9)

99/524

Anti-PT S1 subunit Monoclonal Antibody (4D10)

99/526

Anti-PT S23 subunit Monoclonal Antibody (11E6)

99/528

Anti-PT S23 subunit Monoclonal Antibody (10C9)

99/530

Anti-PT S23 subunit Monoclonal Antibody (10B5)

99/532

Anti-PT S23 subunit Monoclonal Antibody (G9A)

99/534

Anti-PT S23 subunit Monoclonal Antibody (3F6)

99/536

Anti-PT S2 subunit Monoclonal Antibody (3A12)

99/538

Anti-PT S2 subunit Monoclonal Antibody (2H3)

99/540

Anti-PT S2 subunit Monoclonal Antibody (9G8)

99/542

Anti-PT S3 subunit Monoclonal Antibody (7E10)

99/544

Anti-PT S3 subunit Monoclonal Antibody (7G11)

99/546

Anti-PT S3 subunit Monoclonal Antibody (4G5)

99/548

Anti-PT S3 subunit Monoclonal Antibody (2E12)

99/550

Anti-PT S3 subunit Monoclonal Antibody (6F8)

99/552

Anti-PT S3 subunit Monoclonal Antibody (10B8)

99/554

Anti-PT S4 subunit Monoclonal Antibody (7F2)

99/556

Anti-PT S4 subunit Monoclonal Antibody (6B3)

99/558

Anti-PT S4 subunit Monoclonal Antibody (6G8)

99/560

Anti-PT S4 subunit Monoclonal Antibody (9F3)

99/562

Anti-PT S4 subunit Monoclonal Antibody (1H2)

99/564

Anti-PT S4 subunit Monoclonal Antibody (9C6)

99/566

Anti-PT S4 subunit Monoclonal Antibody (6D6)

99/568

Anti-PT S5 subunit Monoclonal Antibody (7E3)

99/570

Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)

99/572

Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)

99/574

Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)

99/586

Influenza Antigen B/Yamanashi/166/98

99/614

Influenza Antigen A/Sydney/5/97

99/616

Yellow Fever Vaccine. WHO International Standard

99/624

Influenza Antigen A/Sydney/5/97

99/642

Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent

99/650

Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent

99/666

Anti-HPA-5b (Minimum Potency) WHO Reference Reagent

99/686

Parvovirus B19 DNA Reference Material for Nucleic Acid Amplification Techniques

99/688

Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent

99/692

Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent

99/706

Anti-Meningococcal human reference serum CDC1992

99/708

Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent

99/714

Influenza Antigen A/Singapore/1/57 (H2N2)

99/720

Chorionic Gonadotrophin, alpha subunit, Human (purified)

99/728

Anti-D Immunoglobulin Control

99/824

Influenza Virus infectious RESVIR 16 (H3N2)

99/828

Influenza Antigen B/Yamanashi/166/98

99/836

Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard

AFP

Alpha-Foetoprotein. WHO International Standard

B2M

Beta-2 Microglobulin. WHO International Standard

BUSB

Botulinum Antitoxin Equine Type B. WHO International Standard

CDS

Anti-Canine Distemper Serum. WHO International Standard

CHAN

Cholera Antitoxin, Goat. WHO International Standard

CHS

Anti-Canine Hepatitis Serum

COT

Clostridium novyi (alpha) Toxoid. WHO Reference Reagent

CWBETATD

Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent

CWEPSILONTD

Clostridium Welchii (Perfringens)( Epsilon) Toxoid CwDT WHO Reference Reagent

DY

Anti-Dysentery (shiga) serum, Equine. WHO International Standard

JNIH-11

Bordetella pertussis anti FHA serum (mouse)

JNIH-12

Bordetella pertussis PT( LPF) anti serum, (mouse)

JNIH-3

Acellular Pertussis Vaccine - 1st IS.

JNIH-4

Bordetella pertussis filamentous haemagglutinin (FHA)

JNIH-5

Bordetella pertussis toxin (PT) 1st IS

MGDS

Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent

NDS

Anti-Newcastle Disease Serum. WHO International Standard

NVIA

Newcastle Disease Vaccine (Inactivated) WHO International Standard

OE

Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard

PE

Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard

PPDA

Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard

PPDBOV

Purified Protein Derivative (PPD) of Bovine Tuberculin WHO International Standard

PPDT

Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard

QF

Anti-Q Fever Serum, Bovine WHO International Standard

RAI

Anti-rabies Immunoglobulin, Human WHO International Standard

RUBI-1-94

Anti-rubella Immunoglobulin, Human WHO International Standard

SES

Swine Erysipelas Serum (anti-N) WHO Reference Reagent

SFS

Anti-Swine Fever Serum WHO International Standard

SMV

Smallpox Vaccine WHO International Standard

SPDS-S2

Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard

SPDS-V

Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard

SPLS

Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent

STA

Staphylococcus Alpha Antitoxin, Equine WHO International Standard

STT

Diphtheria (Schick) Test Toxin WHO International Standard

TE-3

Tetanus Immunoglobulin, Human WHO International Standard

TILI

Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard

TISA

Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard

TYVK

Typhoid Vaccine (acetone-inactivated) WHO International Standard

TYVL

Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard

VI

Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard

YF

Anti-Yellow Fever Serum, monkey WHO Reference Reagent

05/242

IVIG, Anti-D and Negative Control Panel

05/252

Influenza anti B Neuraminidase Serum

06/108

Influenza Virus infectious IVR-116

06/114

Influenza Virus Infectious A/PR/8/34

05/130

Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)

06/124

Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)

RBT/05

Thromboplastin,rabbit,plain(pack of 5 ampoules) with diluent (pack of 5 04/210) WHO International Standard

06/128

Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)

06/140

Pertussis Antiserum(human)1st IS-WHO international Standard.

06/142

Pertussis Antiserum (Human) 1st WHO Reference Reagent

06/166

Antithrombin Concentrate, Human (3rd International Standard)

06/170

Influenza Antigen A/New Caledonia/20/99

06/164

Influenza Virus infectious 1 VR-142

06/206

Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)

06/202

Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)

06/192

Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)

W1044

Anti-Varicella zoster immunoglobulin WHO International Standard

W1066

Rheumatoid Arthritis serum. WHO Reference Reagent

W1063

Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent

W1004

Anti-C complete blood typing serum,human WHO International Standard

W1062

Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent

W1007

Anti-c Incomplete blood typing serum, human WHO International Standard

W1005

Anti-E complete blood typing serum, human WHO International Standard

04/176

Plasmodium falciparum DNA for NAT Assays(1st International Standard)

W1064

Anti-Nuclear factor serum,homogenous(66/233)

06/242

Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)

07/102

Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)

07/104

Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum

07/112

Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23

07/132

Influenza Virus infectious B/Malaysia/2506/2004

07/146

Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)

07/144

Influenza Virus infectious IVR-145,

07/184

Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)

07/226

Influenza Virus Infectious A/New Caledonia/20/99

07/150

Human Plasma Anti-Influenza H5N1 (1st International Standard)

07/246

Influenza Virus Infectious IVR-147

07/222

RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)

07/164

Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)

07/216

Diphtheria Toxoid (Adsorbed) (4th International Standard)

07/272

BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)

07/270

BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)

07/274

BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)

07/214

Positive Control for use in flow cytometry cross matching (FCXM)

07/268

Influenza Virus Infectious B/Brisbane/3/2007

07/228

Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”

07/278

Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)

07/148

Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum

07/290

Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6

07/202

Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)

07/338

Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)

07/318

Meningococcal Group C Polysaccharide

07/306

Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)

07/336

Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60

07/348

Influenza Virus infectious NYMC X-171B

07/358

Influenza Virus infectious NIB-50

07/362

Influenza Virus infectious IVR-149

07/364

Chorionic Gonadotrophin, (5th International Standard)

08/100

Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)

08/142

Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)

08/138

Influenza Virus Infectious B/Florida/4/2006

07/316

Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)

07/350

Blood Coagulation Factor VIII Concentrate (8th I.S.)

08/108

Influenza Virus Infectious NIBRG-91

08/140

Influenza Antigen B/Florida/4/2006

08/154

Influenza Virus Infectious NIBRG-12

08/156

Influenza Virus Infectious NIBRG-23 30060 VE3

08/150

HIV-2 RNA(1st International Standard)

08/204

Thyroid Stimulating Antibody (2nd I.S.)

07/304

Anti-D for assuring operator and test performance

07/326

Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.

07/328

Unfractionated Heparin (6th I.S.)

08/208

Influenza Antigen Hong Kong/1073/99 (H9N2)

08/228

Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91

08/210

Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)

08/202

Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)

08/184

Influenza Antigen B/Malaysia/2506/2004

08/230

Streptodornase (2nd International Standard)

08/214

Meningococcal Serogroup C polysaccharide (1st International Standard)

08/218

Tetanus Toxoid Adsorbed (4th International Standard)

08/216

Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)

08/246

Influenza anti A/Brisbane/10/2007- like HA serum

08/256

C1- Inhibitor, Concentrate (1st International Standard)

08/266

Sex Hormone Binding Globulin.(2nd International Standard)

08/258

Antithrombin, Plasma (3rd International Standard)

08/268

Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107

08/282

Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)

08/158

Fragile X Syndrome gDNA (1st International Genetic Reference Panel)

08/148

Positive control for Luminex based anti-HLA Class II serology

08/126

Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)

08/160

Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)

08/262

C1 Inhibitor (Plasma)(1st International Standard)

08/278

Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))

08/298

Influenza Virus Infectious B/Brisbane/33/2008 30720 E5

08/300

Influenza Virus Infectious IVR-148

08/304

Influenza virus infectious NYMC X-175C

08/356

Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)

09/100

Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)

08/362

Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109

09/112

Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology

09/130

Influenza Virus Infectious NIBRG-122

09/136

Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)

09/154

Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)

09/148

Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)

09/174

Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)

007SP

Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)

09/182

VWF Factor Concentrate (2nd International Standard)

09/172

Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)

09/186

Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)

09/184

Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14

09/196

Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)

09/188

Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)

09/162

Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)

09/170

Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody

SSCLOT4

SSC/ISTH Secondary Coagulation Standard Lot#4

09/222

Human anti-Haemophilus influenzae b reference serum

09/236

Influenza Virus Infectious IVR-153

09/234

Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)

09/242

Fibrinogen Concentrate (B)(2nd International Standard)

09/138

Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)

09/268

Influenza Virus Infectious NIBRG-121xp

09/274

Influenza Virus Infectious NYMC X-185

09/266

GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived

09/140

Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)

09/264

Fibrinogen Plasma (D)(3rd International Standard)

09/280

Influenza Virus Infectious NIB-64

09/260

Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)

09/306

Influenza Virus Infectious NIBRG-147

09/304

Influenza Virus Infectious IVR-155

09/308

Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)

09/310

Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)

09/284

Anti-Human Neutrophil Antibody 1a WHO Reference Reagent

09/316

Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)

09/272

Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)

09/110

Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)

09/296

Pro-Insulin, human (1st International Standard)

10/120

Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum (sheep 516 and 517)

10/104

Reteplase Reference Material

10/130

Diphtheria Monoclonal Antibody

10/128

Diphtheria Polyclonal Antibody

10/132

Tetanus Polyclonal Antibody

10/134

Tetanus Monoclonal Antibody

10/140

Anti-human papillomavirus[HPV] 18 serum (1st International Standard)

10/142

Negative control for Luminex based anti-HLA serology

10/176

Interleukin-29 (Interferon Lamda 1)

10/152

HIV-1 RNA (3rd International standard)

10/178

Endotoxin (3rd International Standard)

10/188

Factor VIII Concentrate (13th British Standard).

10/214

Influenza Anti N2 Neuraminidase Serum SH395 & SH396

10/218

Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)

10/198

Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)

10/226

Influenza Virus Infectious IVR-158

10/202

Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)

10/136-001

HLA-DRB1 Genotyping Reference Panel

10/234

Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)

10/236

Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)

10/242

Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)

10/238

Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)

10/252

Factor VII Concentrate(2nd International Standard)

10/232

Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)

10/272

BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)

10/258

Influenza Antigen A/California/7/2009-like(NIB-74)

10/262

Diphtheria Antitoxin Human IgG(1st International Standard)

10/266

Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)

10/286

Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)

10/280

Anti-HLA Control

11/106

Influenza Virus infectious A/Perth/16/2009

11/108

Influenza Virus infectious NYMC X-187

11/126

Factors II and X Concentrate (4th International standard)

11/130

Influenza Virus Infectious NIBRG-14

11/134

Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)

11/170

Erythropoietin, recombinant, for Bioassay (3rd International Standard)

11/184

High Molecular Weight Urokinase(2nd International Standard)

11/176

(3rd International Standard) Low Molecular Weight Heparin

11/206

Influenza anti-A/Perth/16/2009 HA Serum

11/210

Anti-human CD4 FITC conjugated 0.5ml

11/214

Blood Group Genotyping Reference Panel ((International Reference Reagent)

11/216

Chagas Antibody Reference Panel ( 1st International Standard)

11/218-001

MLH1/MSH2 Exon Copy Number Reference Panel

11/226

Influenza Virus Infectious A/Victoria/361/2011

11/222

Influenza Virus Infectious NIB-79

11/244

Influenza Virus Infectiious NYMC BX-49

12/104

International Standard for IPV 12/104 (3rd International Standard)

11/232

Influenza Virus Infectious B/Texas/6/2011

12/100

Influenza Virus Infectious NYMC X-217

12/106

Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)

12/122

Influenza virus infectious A/turkey/Italy/3889/1999

12/110

Influenza Antigen B/Wisconsin/1/2010 (cell derived)

12/116

Influenza anti-A/Victoria/361/2011-like HA serum

12/112

Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)

12/118

Influenza anti-B/Wisconsin/1/2010-like HA serum

12/114

Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)

12/168

Influenza Antigen A/California/7/09 (H1N1) (NYMCX-181) Egg derived

12/154

Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)

MEF/001

Primary Mouse Embryo Fibroblasts (p0)

11/234

Immunoglobulin E(IgE) human serum (3rd International Standard)

12/176

Methylated Human Serum Albumin (mHSA)

12/188

Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard)

12/198

Influenza virus infectious B/Wisconsin/1/2010 34490 E5

11/242-001

Viral Multiplex Reference

12/202

Influenza virus infectious NYMC BX-39

12/204

Influenza Virus infectious IVR-165

12/208

Parvovirus B19 (3rd International Standard)

12/224

HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)

12/226

HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)

12/290

Influenza Virus Infectious B/Brisbane/36/2012

12/282

Diphtheria Toxin 1Lf/ml

12/298

Influenza Virus Infectious A/Texas/50/2012

12/294

Influenza Virus Infectious NYMC BX-51C

12/252

ADAMTS 13 Plasma (1st International Standard)

12/284

Anti-meningococcal serogroup Y monoclonal antibody

13/106

Influenza Antigen B/Massachusetts/02/2012

13/108

Anti-Meningococcal serogroup B monoclonal antibody

13/112

Influenza Antigen A/Texas/50/2012 (NYMC X-223)

13/126

Influenza anti-B/Brisbane/60/2008-like HA serum

13/116

Influenza Antigen A/Texas/50/2012 (NYMC X-223A)

12/306

Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)

13/134

Influenza Antigen B/Massachusetts/02/2012 (Egg derived)

13/152

Influenza Antigen B/Massachusetts/02/2012 (cell derived)

13/146

C-Peptide, Human (1st International Standard).

13/162

Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)

13/164

Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)

13/100

Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)

13/122

Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)

13/166

Influenza anti-A/Anhui/1/2013 (N9) NA Serum

13/176

Influenza Virus Infectious NIBRG-88

13/178

Influenza Anti-A/Texas/50/2012-like HA Serum

13/180

Influenza A/Anhui/1/2013 (H7) HA Serum

13/182

Influenza Anti-B/Massachusetts/02/2012-like HA Serum

13/132

Antibodies, Human, to Toxoplasma gondii (4th International Standard).

13/198

Influenza Virus Infectious NYMC X-181

13/200

Influenza Virus Infectious NIB-74

13/202

Influenza Virus Infectious NIB-74xp

13/204

TNF Rec II- FC Fusion protein (1st International Standard)

13/206

Plasmin (4th International Standard)

13/212

Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)

13/224

Influenza virus Infectious NIB-85. 36210 E5

13/228

Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4

13/234

Influenza antigen B/Brisbane/60/08

13/216

Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal

13/238

Anti-EV71 serum LOW (WHO International Reference Reagent)

07/296-005

Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques

08/310-005

Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)

13/242

FEIBA Concentrate 2nd NIBSC Working Reference Standard

13/252

Influenza virus infectious NYMC X-223A

234

IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)

1050

IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)

520

IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)

13/246

Meningococcal serogroup A polysaccharide (1st WHO International Standard).

13/256

Influenza virus infectious. NYMC x-233

13/258

Influenza virus infectious NYMC X-233A

13/264

Influenza Virus Infectious NYMC X-223

13/214

HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)

13/248

Influenza virus infectious NIBRG-267

13/250

Influenza Virus Infectious NIBRG-268

14/106

Influenza virus infectious. NYMC BX-51B

14/116

Influenza virus infectious NYMC X-179A

14/118

Influenza virus infectious B/Massachusetts/2/2012

13/218

Polio Anti Sabin type 1 (inactivated) Serum

14/114

JC Virus (JCV) DNA (1st International Standard)

13/220

Polio Anti Sabin type 2 (inactivated) serum

13/222

Polio Anti Sabin type 3 (inactivated) serum

14/140

1st International Standard for Anti EV71 Serum Human

14/144

Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) (sheep SH598)

13/102-001

Hepatitis A Virus RNA Working Reagent

14/146

Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)

14/148

Human Blood Factor IX Concentrate (5th International Standard).

14/156

Meningococcal group X polysaccharide (1st WHO International Standard)

14/160

High titre anti-A in IVIG working reference reagent

14/204

Influenza Virus Infectious B/Brisbane/9/2014

14/206

Influenza virus infectious NYMC X-247

14/232

Influenza Virus Infectious IVR-175

14/150

Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)

14/224

Influenza virus infectious. A/Switzerland/9715293/2013

14/200

Influenza Antigen A/Puerto Rico/8/34 (HINI)

14/226

Influenza Virus Infectious A/South Australia/55/2014

14/228

Influenza Virus Infectious A/Stockholm/6/2014

14/230

Influenza Virus Infectious. A/Norway/466/2014

14/248

Influenza Anti-B/Phuket/3073/2013 HA serum

08/322-005

Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing

14/252

Influenza Antigen B/Phuket/3073/2013

14/250

Influenza Antigen. A/Anhui/1/2013 (H7N9) NIBRG-268

14/254

Influenza Antigen A/Switzerland/9715293/2013 (NIB88)

08/316-006

Epstein-Barr Virus for Nucleic Acid Amplification Techniques

14/274

Influenza Antigen B/Brisbane/9/2014 (Egg Derived)

07/298-005

Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques

08/318-006

Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing

14/174

Botulinum Type A Antitoxin, Equine

14/300

High titre anti-A and anti-B in serum (WHO Reference Reagent).

13/172

Lupus Anticoagulant (1st International Reference Panel)

14/306

Influenza Virus Infectious NYMC X-243 40180 E13

08/120-005

Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques

14/308

Influenza Virus Infectious IVR-178 40200 E7

14/312

Influenza Virus Infectious B/Phuket/3073/2013

14/310

Influenza anti-A/California/7/09 HA serum

14/314

Influenza Virus Infectious NIB-88

07/294-006

Norovirus GII for Nucleic Acid Amplification Techniques

14/320

Influenza Virus Infectious B/Utah/9/2014

14/212

BK Virus (BKV)(1st International Standard)

14/322

Influenza Virus Infectious NIB-91

08/114-005

Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques

11/B608-02

QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1

11/B604-002

QCRFLUAH5QC1 Influenza H5 PC1

15/100

Influenza Antigen B/Utah/9/2014 (Cell Derived)

15/104

Influenza Antigen A/South Australia/55/2014 Cell derived

15/134

Influenza Anti-A Switzerland/9715293/2013-Like HA serum (sheep 618, 619, 628, 634, 635 & 636)

13/B636-03

QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2

15/136

EBOV RNA NP-VP35-GP in-run control

15/138

EBOV RNA VP40-L in-run control

15/130-001

Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)

10/B596-10

QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1

SS-319/20

FITC CD4 Positive Control Cells

15/148

Influenza Virus Infectious NIB-92

12/B620-04

QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2

13/B629-04

QCRHBeQC1-Anti-HBe Quality Control Serum: sample1

15/154

Influenza Virus Infectious NIB-93

08/320-007

Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing

15/158

Influenza Virus Infectious NYMC X-263

99/634-007

HIV-1 RNA Working Reagent 1 (PWS-1) for NAT Assays

15/146

Influenza Virus Infectious B/Brisbane/60/2008

13/B640-01

QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5

11/B606-05

QCRNEGQC1-Negative Quality Control Serum: Sample1

12/B612-04

QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1

12/B623-003

QCRFLUAH1N1QC1-Influenza AH1N1 QC1

15/184

Influenza Virus Infectious NYMC X-263B

15/188

Influenza Virus Infectious NYMC X-263A

15/192

Influenza Virus Infectious A/Hong Kong/4801/2014

15/180

Blood Coagulation Factor XI, Plasma Human 2nd IS

15/B661-01

QCRLYMEIgMQC1 - IgM Anti-Lyme QC1

15/B664-01

QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1

15/B667-01

QCRMEASQC1 Anti-MeaslesQC1

15/194

Influenza Virus Infectious NYMC X-257A

15/B658-01

QCRLYMEQC1 - Anti-Lyme QC1

15/196

Influenza Virus Infectious NYMC X-261

10/B592-09

QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1

14/B655-02

QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1

15/212

Influenza Virus Infectious NYMC BX-53C

15/220

Anti-EBOV plasma, human (WHO Reference Reagent)

15/222

EBOV RNA NP-VP35-GP (WHO Reference Reagent)

15/224

EBOV RNA VP40-L (WHO Reference Reagent)

99/636-007

HIV-1 RNA Working Reagent 2 for NAT assays

14/290

4th HCV RNA Genotype Panel for Nucleic Acid Amplification

08/174-007

Human Coxsackie B4 for Nucleic Acid Amplification Techniques

14/B653-01

QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3

15/B673-01

QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1

12/B611-02

Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1

15/236

Influenza Anti-A/Hong Kong/4801/2014 Like HA serum (sheep 640,641,642,643)

16/286

Influenza Antigen A/Hong Kong/4801/2014 (NYMCX-263B) (Egg derived antigen)

15/234

Influenza Virus Infectious B/Texas/2/2013 41340 E7

09/B558-06

QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices

13/B631-04

QCRHBsGQC1-HBsAg Quality Control Serum: Sample1

15/238

Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)

14/B654-02

QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1

03/104-016

HTLV-1 (antibody) Monitor Sample

12/B613-04

QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2

07/286-013

0.05 IU HBsAg Monitor Sample

15/250

Influenza Virus Infectious NYMC BX-31

13/B644-02

QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3

15/252

Influenza Virus Infectious A/California/7/2009

15/240

Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)

15/242

Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)

15/B680-01

QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1

15/B669-01

QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1

14/240-003

British Working Standard for Anti-HCV

07/B498-17

QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1

08/324-005

Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing

08/176-005

Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques

99/750-021

HIV-1 (antibody) British Working Standard)

15/274

Influenza Virus Infectious NYMC BX-59A

15/294

Influenza virus infectious NYMC BX-59B

08/118-005

Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques

15/B675-02

QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2

13/B642-05

QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1

13/B650-02

QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1

99/674-016

HIV-2 (antibody) Monitor Sample

14/242-002

Anti-HCV (1 in 8 dilution)(British Working Standard)

15/298

Influenza Virus Infectious B/Brisbane/46/2015

16/B685-01

QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2

16/100

Influenza Anti-A/Hong Kong/4801/2014-like HA Serum

15/300

Influenza Virus Infectious NYMC BX-35 41950 E11

16/114

Influenza anti - A/California/7/09 HA serum

16/110-001

Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)

07/300-005

Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques

15/312

Influenza Anti-B/Brisbane/60/2008 HA Serum

08/178-005

Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques

16/106

Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)

07/288-014

Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml

13/168-002

Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques

16/118

Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)

09/B584-13

QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1

15/B678-01

QCRPARVB19QC1 Anti-Parvovirus B19QC1

16/B683-01

QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1

14/198-002

HBV,HCV,HIV Multiplex

09/132-004

Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing

99/710-020

HIV-1 (antibody) (1 in 5 dilution) British Working Standard

13/B634-03

QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2

13/B625-05

QCRHBsGQC2-HBsAg Quality Control Serum: Sample2

14/246

Influenza Virus Infectious NIBRG-301

15/160

Influenza Virus Infectious NIBRG-306

15/B671-01

QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1

16/166

Diphtheria Antitoxin Equine DI.

16/200

Influenza Virus Infectious NIB-58

09/B588-08

QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1

08/180-005

Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques

16/208

Influenza Virus Infectious NIB-97 42090 E7

16/242

Influenza Virus Infectious NIB-98 42110 E7

16/238

Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)

10/B592-10

QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1

13/B627-04

QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1

16/248

Influenza Virus Infectious NYMC X-275 42020 E11

16/270

Influenza Virus Infectious IVR-180 42400 E3/D7/E1

14/B651-02

QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2

12/B620-05

QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2

16/274

Influenza Virus Infectious X-275A 42010 E13

16/268

Influenza Virus Infectious X-273

16/298

Influenza Antigen A/Michigan/45/2015 (NYMC X-275)

16/304

Influenza anti-A/Michigan/45/2015-like HA serum (Sheep 661 and 665)

16/292

Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)

RTF/16

Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016. Panel

RBT/16

Thromboplastin, Rabbit, Plain 5th International Standard 2016. Panel

00/410

MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)

00/416

Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

00/418

MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)

00/422

High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

00/440

Influenza Antiserum A/Singapore/1/57 (H2)

00/442

Influenza anti B/Yamanashi/166/98 Serum

00/464

Streptokinase (3rd International Standard 2001)

00/500

Botulinum Type A-E Antitoxin, Human Serum

00/530

Influenza Virus infectious B/Sichuan/379/99

00/542

Influenza anti- A/Chick/Scotland/59 (H5N1) Serum

00/544

Influenza Virus infectious B/Victoria/504/00

00/546

Influenza Antigen B/Johannesburg/5/99

00/552

Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)

00/556

Influenza anti-B/Johannesburg/5/99/ Serum

00/562

Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)

00/572

Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)

00/574

Interferon Beta SER17 Mutein (Human, rDNA derived)

00/576

Interferon Beta (Human, Fibroblast-derived, Glycosylated)

00/614

Influenza virus infectious B/Guangdong/120/2000

01/412

Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody

01/420

Interleukin-17 (Human rDNA derived)(International Reference Reagent)

01/424

Vascular Endothelial Growth Factor, Human rDNA derived

01/426

Meningococcal group Y polysaccharide

01/428

Meningococcal serogroup W polysaccharide

01/450

Influenza anti B/Guangdong/120/2000 Serum

01/452

Influenza anti A/Panama/2007/99 (H3N2) HA serum

01/506

Botulinum type F antitoxin, equine

01/508

Botulinum type C antitoxin, equine

01/510

Botulinum Antitoxin Equine Type D

01/512

Botulinum type G antitoxin, equine

01/514

Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody

01/538

Anti-Meningococcal Serosubtype P1.16 mAb

01/546

Influenza Antigen B/Guangdong/120/2000

01/572

Anti-D Immunoglobulin(2nd International Standard)

01/580

Thrombin, human(2nd International Standard)

01/600

Anti-Toxoplasma IgG, Human(International Standard)

01/602

Anti-Parvovirus B19, plasma, human(2nd International Standard)

01/612

Influenza Virus infectious B/Hawaii/10/01

01/614

Influenza Antigen A/New Caledonia/20/99

02/102

Influenza anti A/Panama/2007/99 Serum

02/144

Anti-Meningococcal Serosubtype P1.15 mAb

02/148

Anti-Meningococcal Serosubtype P1.4 mAb

02/168

Prekallikrein Activator (PKA), Human(2nd International Standard)

02/178

Anti-Meningococcal Serosubtype P1.2 mAb

02/180

Anti-Meningococcal Serotype P2.2a mAb

02/182

Anti-Japanese Encephalitis Virus Plasma, Human

02/184

Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human

02/206

Factor XIII Plasma, Human (1st International Standard)

02/210

HIV (antibody), 1st International Reference Panel

02/226

IVIG negative control for use with IVIG + anti-D(International Reference Reagent)

02/228

IVIG + anti-D for use with negative control IVIG(International Reference Reagent)

02/230

Biotinylated Brad-5 (Bio-Brad-5)

02/232

Tetanus Toxoid (Non-Adsorbed)

02/254

Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)

02/262

Influenza Virus infectious B/Brisbane/32/2002

02/286

Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)

02/294

Influenza Antiserum A/chick/Italy/1347/99 (H7N1)

02/308

Anti-Meningococcal Serotype P3.4 mAb

02/310

Anti-Meningococcal Serotype P3.15 mAb

02/318

Botulinum Antitoxin Equine Type E

02/320

Anti-Meningococcal Serosubtype P1.3 mAb

02/336

Influenza Antigen A/New Caledonia/20/99

02/338

Influenza anti A/Panama/2007/99 Serum

02/342

Protein C Plasma, Human(2nd International Standard)

03/110

Influenza anti B/Shangdong/9/97 Serum

03/114

Anti-Meningococcal Serosubtype P1.1 mAb

03/116

Blood Coagulation Factor V, Plasma Human (1st International Standard)

03/124

Thrombopoietin ( Human rDNA derived)

03/142

Anti-Meningococcal Serosubtype P1.14 mAb

03/148

Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)

03/150

Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)

03/152

Anti-HPA-1a (International Standard)

03/164

Anti-B minimum potency reference preparation(International Standard)

03/178

Vitamin B12, Serum Folate and holoTC (International standard)

03/182

Anti-Meningococcal Serotype P3.21 mAb

03/188

Anti-A minimum potency reference preparation(International Standard)

03/190

Anti-HPA-3a(minimum potency)(International Reference Reagent)

03/192

Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)

03/198

Influenza Virus infectious A/Kumamoto/102/02

03/200

Interleukin - 18 (Human rDNA derived)(International Reference Reagent)

03/210

Anti-Meningiococcal Serosubtype P1.6 mAb

03/212

Influenza anti A/Wyoming/03/03 Serum

03/220

Influenza Antigen A/Wyoming/03/03

03/224

Anti-Meningococcal Serosubtype P1.10 mAb

03/226

Anti-Meningococcal Serosubtype P1.5 mAb

03/228

Protein S, Plasma, Human(2nd International Standard)

03/236

Anti-Meningococcal Serosubtype P1.13 mAb

03/242

Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum

03/244

Influenza Antiserum A/chick/Germany/N/49

03/258

Influenza Antigen A/New Caledonia/20/99 (IVR-116)

03/262

Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)

04/122

Anti-Meningococcal Serosubtype P1.12 mAb

04/132

IVIG + Anti-D for use with negative control IVIG

04/140

IVIG Negative Control for use with IVIG & Anti-D

04/150

Tetanus Toxoid For Flocculation Test(2nd International Standard)

04/160

Influenza Virus infectious NYMC X-147

04/166

TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)

04/170

Influenza Virus infectious A/Wellington/1/2004

04/172

Influenza Virus infectious IVR-139

04/198

Anti-Meningococcal Serotype P3.1 mAb

04/200

Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)

04/202

Influenza Antigen B/ Jiangsu/10/2003

04/214

Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)

04/224

Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004

04/228

Influenza anti B/ Neuraminidase Serum

04/230

Influenza anti N1 Neuraminidase Serum

04/242

Influenza anti B/Jiangsu/10/2003 HA Serum

04/246

Anti-Meningococcal Serogroup W-135 mAb

04/248

Anti-Meningococcal Serosubtype P1.19 mAb

04/252

Protein C Concentrate, Human(1st International Standard)

04/260

Influenza anti A/New Caledonia/20/99 HA Serum

04/262

Influenza anti A/New York/55/2004 HA Serum

04/264

Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)

05/102

Influenza Virus infectious NYMC BX-7

05/106

Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)

05/110

Influenza Virus infectious A/California/7/2004

05/112

Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).

05/122

Syphilitic plasma IgG (human)(1st International Standard)

05/132

Syphilitic plasma IgG and IgM (human)(1st International Standard)

05/134

Anti-human papillomavirus type 16 serum (1st International Standard)

05/138

Influenza Virus infectious B/Shanghai/361/2002

05/162

Alpha-1-Antitrypsin, plasma derived(1st International standard)

05/190

Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody

05/192

Anti Meningococcal Serotype P2.2b Monoclonal Antibody

05/234

Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)

05/236

Influenza anti A/Wisconsin/67/2005 Serum

2BADS

Anti-Brucella Abortus Serum, Bovine (International Standard)

2CPBETAAT

Clostridium Perfringens Beta Antitoxin (2nd International Standard)

2CPEPSILONAT

Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)

59/015

Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine

59/016

Corticotrophin (ACTH), Porcine (3rd International Standard)

59/021

Botulinum Antitoxin Equine Type A

60/001

Botulinum Antitoxin Equine Type B

60/013

Tetanus Antitoxin, Equine, for Bioassay

61/001

Botulinum Antitoxin Equine Type D (1st International Standard)

62/001

Serum Gonadotrophin, Equine (2nd International Standard)

62/014

Lysine Vasopressin, Porcine

63/005

Gas Gangrene Antitoxin (Cl. Histolyticum), Equine

63/007

Diphtheria Antitoxin, Equine, for Flocculation Test

64/002

Rheumatoid Arthritis Serum

64/014

Gas Gangrene Antitoxin (Cl. Septicum), Equine

64/024

Gas Gangrene Antitoxin (Cl. Oedematiens), Equine

65/093

Anti-Thyroglobulin Serum, Human (International Reference reagent)

65/119

Renin, Porcine

65/122

Long-acting Thyroid Stimulator, Human

66/021

Tetanus Antitoxin, Equine, for Flocculation Test

66/138

Gastrin II, Porcine

66/153

Diphtheria Antitoxin, Equine

66/233

Anti-Nuclear Factor Serum (Homogenous) Human

66/387

Anti-thyroid Microsome Serum, Human

67/037

Immunoglobulin D (IgD) Serum, Human

67/086

Immunoglobulins G, A, M Serum Human (International Standard)

67/099

Immunoglobulins G, A & M Serum Human

67/182

Anti-Rubella Serum, Human

67/183

Primary Biliary Cirrhosis Serum, Human

68/340

Anti-Nucleolar Factor Plasma, Human

68/356

Renin, Human (International Standard)

69/017

Diphtheria Toxoid, Plain

69/065

Autoimmune Antibody to Human Spermatazoa

69/194

Glucagon, Porcine (First International Standard)

70/302

Angiotensin II (25µg)

71/281

Anti-Malaria Plasma P Vivax

71/326

Anti-Malaria Plasma Vivax Ng2

71/328

Angiotensin I

72/092

Anti-malaria Plasma: Plasmodium falciparum (Ghana)

72/096

Anti-Malaria Serum (P.Malariae)

72/341

Anti-Malaria Plasma P Falciparum

72/345

Anti-Malaria Plasma P Falciparum

72/348

Anti-Malaria Plasma P Vivax

73/515

Anti-D (Rho) Antibodies, Human

73/545

Placental Lactogen, Human (International Reference Preparation)

73/554

Cholera Vaccine (Inaba)

73/556

Cholera Vaccine (Ogawa)

73/601

Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)

74/520

Serum Proteins (Other than Immunoglobulins) Human

74/555

Corticotrophin (ACTH), Human

74/581

Ancrod (1st International Reference Preparation)

74/586

Corticotrophin (ACTH), Porcine (International Working Standard)

75/506

Cocksfoot Pollen Extract

75/533

Chorionic Gonadotrophin, Human, for Radioiodination

75/535

Chorionic Gonadotrophin beta, Human, for Radioiodination

75/551

Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)

75/569

Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)

75/595

Blood Coagulation Factor Xa, Bovine

76/508

Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination

76/515

Mannan (C. Albians) Purified

76/522

Opacity 5IRP WHO International Standard

76/525

Anti-Birch Pollen Serum, Human

76/547

Influenza anti A/Victoria/3/75 Serum(goat)

76/575

Oxytocin(4th International Standard)

77/503

Anti-Cocksfoot Serum, Human

77/512

Lysine Vasopressin(1st International Standard)

77/530

Influenza Antigen A/New Jersey/8/76

77/531

Influenza anti A/New Jersey/8/76(H1N1) Serum(sheep)

77/568

Influenza anti B/Hong Kong/8/73 Serum(sheep)

77/584

Anti-D Pteronyssinus Serum, Human

77/600

Mannan (C. Albicans) Purified

77/616

Twelve Grass Pollen Extract

77/643

Secretin

77/662

Acarus Siro Extract

77/664

Glycyphagus destructor Extract

78/517

Tyrophagus Putrescentiae Extract

78/543

Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard)

78/545

Anti-Aspergillus fumigatus Serum, Human

78/554

Luteinizing Hormone, Pituitary, alpha subunit (International Standard)

78/556

Luteinizing Hormone, Pituitary, beta subunit (International standard)

78/560

Influenza Antigen A/Texas/1/77

78/569

Influenza anti A/Texas/1/77 Serum (sheep)

78/575

Aspergillus Fumigatus Extract

78/582

Tyrophagus Longior Extract

78/628

Bee Venom

79/500

Parathyroid Hormone, Human (1st International Ref. Preparation)

79/516

Influenza anti A/Brazil/11/78 Serum (goat)

79/552

Influenza Antigen A/USSR/92/77

79/558

Influenza Antigen A/USSR/92/77

79/560

Influenza Antigen A/Brazil/11/78

79/568

Influenza Antigen B/Hong Kong/8/73

79/572

Prekallikrein Activator (PKA), Human

505

Growth Hormone, Human, Pituitary. WHO International Standard

80/517

Influenza Antigen A/Bangkok/1/79

80/519

Influenza Antigen B/Singapore/222/79

80/523

Influenza anti B/Singapore/222/79 Serum

80/525

Influenza anti A/Bangkok/1/79 Serum (sheep)

80/590

Tetracosactide. International Ref. Preparation

81/535

Luteinizing Hormone, Human, Pituitary (3rd International Standard)

81/565

Thyroid Stimulating Hormone, Human. WHO International Standard

82/508

Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment

82/512

Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment

82/518

Dermatophagoides Pteronyssinus Extract. WHO International Standard

82/520

Timothy Pollen Extract. WHO International Standard

82/585

Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)

82/587

Interferon Gamma (Human, Leukocyte derived)

82/632

Parathyroid Hormone, Bovine. WHO International Standard

82/652

Human Serum Vitamin B12, Pernicous anaemia

83/500

Insulin, Human. WHO International Standard

83/501

Beta Thromboglobulin, Purified Human. WHO International Standard

83/505

Platelet Factor 4 Human, Purified. WHO International Standard

83/511

Insulin, Bovine. WHO International Standard

83/514

Interferon alpha-1D, (Human rDNA derived) WHO International Standard

83/515

Insulin, Porcine. WHO International Standard

83/537

Influenza Antigen A/Philippines/2/82

83/545

Influenza anti A/Philippine/2/82 Serum (sheep)

83/550

Influenza Antigen A/Brazil/11/78

83/575

Follicle Stimulating Hormone, Pituitary. WHO International Standard

83/573

Prolactin, Human. WHO International Standard

84/514

Proinsulin, Bovine. International Ref. Preparation

84/522

Birch Pollen Extract. WHO International Standard

84/528

Proinsulin, Porcine. International Ref. Reagent

84/538

Influenza Antigen A/Chile/1/83

84/542

Influenza Antigen B/Norway/1/84

84/581

Short Ragweed Pollen Extract. WHO International Standard

84/614

Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard

84/628

Anti-c Serum, Human

84/636

Influenza anti B/USSR/100/83 Serum(sheep)

84/640

Influenza anti A/Chile/1/8 Serum(sheep)

84/677

Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)

84/685

Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard

85/506

C-Reactive Protein, Human. WHO International Standard

85/516

Influenza anti A/Equine/Kentucky/1/81 HA Serum (sheep)

85/520

Influenza Antigen A/Equine/Kentucky/1/81

85/522

Thyroid Stimulating Hormone beta subunit

85/551

Anti-Rye Grass Serum, Human

85/616

Haemoglobin F Lysate, Raised. WHO Reference Reagent

85/669

Atrial Natriuretic Factor, Human. WHO International Standard

86/500

Interleukin- 2 (Human, rDNA derived)(2nd International Standard)

86/536

Angiotensin I Human Type Synthetic

86/538

Angiotensin II (2.5µg)

86/552

Interleukin-1 Beta (Human, rDNA derived)

86/576

Influenza Antigen A/Mississippi/1/85

86/590

Influenza anti A/Mississippi/1/85 Serum(sheep)

86/592

Influenza anti B/Ann Arbor/1/86/HA Serum (sheep)

86/630

Influenza Antigen B/Ann Arbor/1/86

86/632

Interleukin-1 alpha (Human rDNA derived) WHO International Standard

86/678

Interleukin-1 alpha (Human, rDNA derived)

86/680

Interleukin-1 beta (Human, rDNA derived) WHO International Standard

86/690

Inhibin, Porcine WHO International Standard

87/510

Influenza Antigen A/Equine/Miami/63

87/578

Influenza anti A/Leningrad/360/86 Serum (sheep)

87/584

Influenza Antigen A/Leningrad/360/86

87/586

Interferon Gamma (Human, rDNA derived)

87/640

Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent

87/654

Anti-Ferritin Monoclonal Antibody (1)

87/662

Anti-Ferritin Monoclonal Antibody (2)

87/714

Influenza Antigen A/Sichuan/2/87

87/774

Influenza Antigen B/Victoria/2/87

88/522

Bordetella pertussis (Whole cell vaccine) 3BRP

88/532

Tumour Necrosis Factor alpha (Mouse, rDNA derived)

88/554

Influenza Antigen B/Beijing/1/87

88/556

Calcitonin, Eel WHO International Standard

88/638

Thyroxine-binding globulin. WHO International Standard

88/646

Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard

88/654

Influenza Antigen A/England/427/88

88/656

Interleukin-4 (Human, rDNA derived) WHO International Standard

88/672

Influenza anti A/Sichuan/2/87 Serum(sheep)

88/678

Influenza anti B/Beijing/1/87 Serum(sheep)

88/846

Influenza anti A/England/427/88 Serum(sheep)

89/512

Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard

89/514

Transforming Growth Factor beta-1 (Human, rDNA derived)

89/516

Transforming Growth Factor beta-1 (Bovine)

89/518

Transforming Growth Factor beta-2 (Bovine)

89/520

Interleukin-8 (Human, rDNA derived) WHO International Standard

89/530

Anti-Bordetella pertussis serum (Human)

89/544

Renin, Human, rec DNA

89/548

Interleukin-6 (Human, rDNA derived) WHO International Standard

89/568

Influenza Antigen A/OMS/5389/88

89/594

Bordetella pertussis (W28) LPS 2ug

89/596

Bordetella pertussis anti-agglutinogen 1(rabbit)

89/598

Bordetella pertussis anti-agglutinogen 2 (rabbit)

89/600

Bordetella pertussis anti-agglutinogen 3 (rabbit)

89/620

Calcitonin, Human. WHO International Standard

89/666

Haemoglobin A2 Lysate, Raised. WHO Reference Reagent

89/670

Bordetella pertussis (W28) LPS25ug

90/500

Influenza Antigen A/Shanghai/16/89

90/502

Influenza Antigen A/Guizhou/54/89

90/504

Influenza anti A/Guangdong/39/89 Serum(sheep)

90/520

Bordetella pertussis, filamentous haemagglutinin (FHA)

90/530

Interleukin-7 (Human, rDNA derived) WHO Reference Reagent

90/534

Mumps Vaccine (Live) WHO Reference Reagent

90/586

Interleukin-5 (Human, rDNA derived) WHO Reference Reagent

90/636

HIV-1 P24 Antigen WHO International Standard

90/654

Bordetella pertussis 69kD

90/690

Anti-Varicella-Zoster Antibody

90/696

Transforming Growth Factor beta-2, Human, rec DNA

90/712

Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard

90/784

Influenza Virus infectious NIB-26 (H3N2)

91/510

Interleukin-3 (Human, rDNA derived) WHO International Standard

91/530

Epidermal Growth Factor (Human, rDNA derived) WHO International Standard

91/550

Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent

91/554

Insulin-like growth Factor 1 WHO International Standard

91/562

Anti-D for use with papain preparation 92/658

91/612

Influenza anti A/Taiwan/1/86 Serum (sheep)

91/624

Inhibin A, Human, recombinant WHO International Standard

91/626

Activin A, Human, Recombinant. WHO Reference Reagent

91/656

Interleukin-4 (Mouse, rDNA derived)

91/658

Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)

91/662

Interleukin-3 (Mouse, rDNA derived)

91/670

Influenza Virus infectious NIB-27 (H1N1)

91/678

Interleukin-9 (Human,rDNA derived) WHO Reference Reagent

91/682

Stem Cell Factor (Human rDNA derived) WHO Reference Reagent

91/688

Rubella Vaccine (Live) WHO Reference Reagent

92/510

Follicle Stimulating Hormone, Human, recombinant. WHO International Standard

92/512

Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard

92/518

Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)

92/520

Rantes (Human, rDNA derived)

92/530

Influenza Antigen A/Texas/36/91

92/582

Influenza anti B/Yamagata/16/88 Serum(sheep)

92/628

Influenza Antigen B/Yamagata/16/88

92/632

Influenza anti A/Beijing/352/89 (H3N2) Serum (sheep)

92/644

Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)

92/648

Measles Vaccine (Live) WHO Reference Reagent

92/654

Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard

92/658

Papain preparation for use with Anti-D preparation 91/562

92/680

Serum amyloid A protein. WHO International Standard

92/734

Influenza Virus infectious A/Beijing/32/92 (H3N2)

92/738

Influenza Virus infectious A/Shanghai/24/90

92/788

Interleukin-11 (Human, rDNA derived) WHO Reference Reagent

92/794

Monocyte Chemoattractant Protein-1 (Human,rDNA derived)

93/500

Influenza Antigen A/Beijing/32/92

93/516

Influenza Antigen A/Shanghai/24/90

93/518

Influenza anti A/Beijing/32/92 (H3N2) Serum (sheep)

93/522

Influenza anti A/Shanghai/24/90 (H3N2) Serum (sheep)

93/526

Batroxobin

93/556

Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent

93/560

Insulin-like growth Factor Binding Protein-3

93/562

Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent

93/564

Oncostatin M (Human, rDNA derived) WHO Reference Reagent

93/566

Interleukin-2 (Mouse, rDNA derived)

93/568

Influenza Virus infectious A/Beijing/359/89 (H3N2)

93/572

Influenza Virus infectious A/Guizhou/54/89 (H3N2)

93/574

Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent

93/668

Interleukin-1 beta (Mouse, rDNA derived)

93/672

Interleukin-1 alpha (Mouse, rDNA derived)

93/686

Influenza Virus infectious A/Shangdong/9/93 (H3N2)

93/692

Influenza Virus infectious B/Panama/45/90

93/722

Interleukin-10 (Human rDNA derived) WHO Reference Reagent

93/730

Interleukin-6 (Mouse, rDNA derived)

93/740

Interleukin-7 (Mouse, rDNA derived)

93/816

Influenza Virus infectious A/Harbin/15/92 (H3N2)

94/500

Influenza Antigen B/Panama/45/90

94/504

Influenza anti A/Shanghai/9/93 Serum(sheep)

94/516

Influenza Antigen A/Shangdong/9/93

94/520

Influenza anti B/Panama/45/90 Serum(sheep)

94/532

Pertussis Vaccine (Whole Cell) WHO International Standard

94/572

Ferritin, Human, recombinant. WHO International Standard

94/622

Interleukin-13 (Human, rDNA derived) WHO Reference Reagent

94/674

Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent

94/684

Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent

94/718

Staphylokinase, rec (STAR)

94/728

Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard

94/730

Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard

94/754

Interferon Omega (Human, rDNA derived) WHO International Standard